vs

Side-by-side financial comparison of ITT INC. (ITT) and Sylvamo Corp (SLVM). Click either name above to swap in a different company.

ITT INC. is the larger business by last-quarter revenue ($1.1B vs $890.0M, roughly 1.2× Sylvamo Corp). ITT INC. runs the higher net margin — 12.5% vs 3.7%, a 8.8% gap on every dollar of revenue. On growth, ITT INC. posted the faster year-over-year revenue change (13.5% vs -8.2%). ITT INC. produced more free cash flow last quarter ($187.4M vs $38.0M). Over the past eight quarters, ITT INC.'s revenue compounded faster (7.6% CAGR vs -0.8%).

ITT Inc., formerly ITT Corporation, is an American manufacturing company based in Stamford, Connecticut. The company produces specialty components for the aerospace, transportation, energy, and industrial markets. ITT's three business units are Industrial Process, Motion Technologies, and Connect and Control Technologies.

Sylvamo Corp is a leading global manufacturer of sustainable paper and pulp products. Its core offerings include uncoated printing paper, packaging paper, and market pulp, serving office supplies, publishing, commercial printing, and packaging segments across North America, Europe, and Latin America.

ITT vs SLVM — Head-to-Head

Bigger by revenue
ITT
ITT
1.2× larger
ITT
$1.1B
$890.0M
SLVM
Growing faster (revenue YoY)
ITT
ITT
+21.7% gap
ITT
13.5%
-8.2%
SLVM
Higher net margin
ITT
ITT
8.8% more per $
ITT
12.5%
3.7%
SLVM
More free cash flow
ITT
ITT
$149.4M more FCF
ITT
$187.4M
$38.0M
SLVM
Faster 2-yr revenue CAGR
ITT
ITT
Annualised
ITT
7.6%
-0.8%
SLVM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ITT
ITT
SLVM
SLVM
Revenue
$1.1B
$890.0M
Net Profit
$131.7M
$33.0M
Gross Margin
35.5%
Operating Margin
17.0%
8.9%
Net Margin
12.5%
3.7%
Revenue YoY
13.5%
-8.2%
Net Profit YoY
3.7%
-59.3%
EPS (diluted)
$1.64
$0.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ITT
ITT
SLVM
SLVM
Q4 25
$1.1B
$890.0M
Q3 25
$999.1M
$846.0M
Q2 25
$972.4M
$794.0M
Q1 25
$913.0M
$821.0M
Q4 24
$929.0M
$970.0M
Q3 24
$885.2M
$965.0M
Q2 24
$905.9M
$933.0M
Q1 24
$910.6M
$905.0M
Net Profit
ITT
ITT
SLVM
SLVM
Q4 25
$131.7M
$33.0M
Q3 25
$126.9M
$57.0M
Q2 25
$121.0M
$15.0M
Q1 25
$108.4M
$27.0M
Q4 24
$127.0M
$81.0M
Q3 24
$161.1M
$95.0M
Q2 24
$119.2M
$83.0M
Q1 24
$111.0M
$43.0M
Gross Margin
ITT
ITT
SLVM
SLVM
Q4 25
35.5%
Q3 25
35.6%
Q2 25
35.7%
Q1 25
34.6%
Q4 24
34.1%
Q3 24
35.5%
Q2 24
34.9%
Q1 24
33.0%
Operating Margin
ITT
ITT
SLVM
SLVM
Q4 25
17.0%
8.9%
Q3 25
18.0%
11.6%
Q2 25
18.0%
3.8%
Q1 25
16.5%
5.4%
Q4 24
17.2%
11.2%
Q3 24
23.5%
15.5%
Q2 24
17.6%
13.1%
Q1 24
16.4%
8.0%
Net Margin
ITT
ITT
SLVM
SLVM
Q4 25
12.5%
3.7%
Q3 25
12.7%
6.7%
Q2 25
12.4%
1.9%
Q1 25
11.9%
3.3%
Q4 24
13.7%
8.4%
Q3 24
18.2%
9.8%
Q2 24
13.2%
8.9%
Q1 24
12.2%
4.8%
EPS (diluted)
ITT
ITT
SLVM
SLVM
Q4 25
$1.64
$0.81
Q3 25
$1.62
$1.41
Q2 25
$1.52
$0.37
Q1 25
$1.33
$0.65
Q4 24
$1.54
$1.91
Q3 24
$1.96
$2.27
Q2 24
$1.45
$1.98
Q1 24
$1.35
$1.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ITT
ITT
SLVM
SLVM
Cash + ST InvestmentsLiquidity on hand
$1.7B
$198.0M
Total DebtLower is stronger
$521.5M
$763.0M
Stockholders' EquityBook value
$4.1B
$966.0M
Total Assets
$6.3B
$2.8B
Debt / EquityLower = less leverage
0.13×
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ITT
ITT
SLVM
SLVM
Q4 25
$1.7B
$198.0M
Q3 25
$516.4M
$146.0M
Q2 25
$467.9M
$183.0M
Q1 25
$439.8M
$220.0M
Q4 24
$439.3M
$309.0M
Q3 24
$460.9M
$414.0M
Q2 24
$425.5M
$213.0M
Q1 24
$423.0M
$218.0M
Total Debt
ITT
ITT
SLVM
SLVM
Q4 25
$521.5M
$763.0M
Q3 25
$577.7M
$778.0M
Q2 25
$622.5M
$767.0M
Q1 25
$4.5M
$794.0M
Q4 24
$232.6M
$782.0M
Q3 24
$467.8M
$883.0M
Q2 24
$190.0M
$894.0M
Q1 24
$230.5M
$921.0M
Stockholders' Equity
ITT
ITT
SLVM
SLVM
Q4 25
$4.1B
$966.0M
Q3 25
$2.7B
$977.0M
Q2 25
$2.6B
$959.0M
Q1 25
$2.8B
$908.0M
Q4 24
$2.8B
$847.0M
Q3 24
$2.7B
$937.0M
Q2 24
$2.6B
$830.0M
Q1 24
$2.6B
$889.0M
Total Assets
ITT
ITT
SLVM
SLVM
Q4 25
$6.3B
$2.8B
Q3 25
$5.1B
$2.7B
Q2 25
$5.0B
$2.7B
Q1 25
$4.8B
$2.6B
Q4 24
$4.7B
$2.6B
Q3 24
$4.9B
$2.9B
Q2 24
$4.4B
$2.7B
Q1 24
$4.4B
$2.6B
Debt / Equity
ITT
ITT
SLVM
SLVM
Q4 25
0.13×
0.79×
Q3 25
0.22×
0.80×
Q2 25
0.24×
0.80×
Q1 25
0.00×
0.87×
Q4 24
0.08×
0.92×
Q3 24
0.17×
0.94×
Q2 24
0.07×
1.08×
Q1 24
0.09×
1.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ITT
ITT
SLVM
SLVM
Operating Cash FlowLast quarter
$227.8M
$94.0M
Free Cash FlowOCF − Capex
$187.4M
$38.0M
FCF MarginFCF / Revenue
17.8%
4.3%
Capex IntensityCapex / Revenue
3.8%
6.3%
Cash ConversionOCF / Net Profit
1.73×
2.85×
TTM Free Cash FlowTrailing 4 quarters
$547.5M
$44.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ITT
ITT
SLVM
SLVM
Q4 25
$227.8M
$94.0M
Q3 25
$173.9M
$87.0M
Q2 25
$153.7M
$64.0M
Q1 25
$113.4M
$23.0M
Q4 24
$223.2M
$164.0M
Q3 24
$123.9M
$163.0M
Q2 24
$157.7M
$115.0M
Q1 24
$57.8M
$27.0M
Free Cash Flow
ITT
ITT
SLVM
SLVM
Q4 25
$187.4M
$38.0M
Q3 25
$146.2M
$33.0M
Q2 25
$137.3M
$-2.0M
Q1 25
$76.6M
$-25.0M
Q4 24
$186.8M
$100.0M
Q3 24
$87.3M
$119.0M
Q2 24
$134.5M
$62.0M
Q1 24
$30.1M
$-33.0M
FCF Margin
ITT
ITT
SLVM
SLVM
Q4 25
17.8%
4.3%
Q3 25
14.6%
3.9%
Q2 25
14.1%
-0.3%
Q1 25
8.4%
-3.0%
Q4 24
20.1%
10.3%
Q3 24
9.9%
12.3%
Q2 24
14.8%
6.6%
Q1 24
3.3%
-3.6%
Capex Intensity
ITT
ITT
SLVM
SLVM
Q4 25
3.8%
6.3%
Q3 25
2.8%
6.4%
Q2 25
1.7%
8.3%
Q1 25
4.0%
5.8%
Q4 24
3.9%
6.6%
Q3 24
4.1%
4.6%
Q2 24
2.6%
5.7%
Q1 24
3.0%
6.6%
Cash Conversion
ITT
ITT
SLVM
SLVM
Q4 25
1.73×
2.85×
Q3 25
1.37×
1.53×
Q2 25
1.27×
4.27×
Q1 25
1.05×
0.85×
Q4 24
1.76×
2.02×
Q3 24
0.77×
1.72×
Q2 24
1.32×
1.39×
Q1 24
0.52×
0.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ITT
ITT

Industrial Process$423.1M40%
Motion Technologies$360.8M34%
Connect Control Technologies$271.2M26%

SLVM
SLVM

Segment breakdown not available.

Related Comparisons